These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38742364)
1. Homologous-targeting biomimetic nanoparticles co-loaded with melittin and a photosensitizer for the combination therapy of triple negative breast cancer. Zhang T; Bai L; You R; Yang M; Chen Q; Cheng Y; Qian Z; Wang Y; Liu Y J Mater Chem B; 2024 Jun; 12(22):5465-5478. PubMed ID: 38742364 [TBL] [Abstract][Full Text] [Related]
2. Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy. Liu H; Hu Y; Sun Y; Wan C; Zhang Z; Dai X; Lin Z; He Q; Yang Z; Huang P; Xiong Y; Cao J; Chen X; Chen Q; Lovell JF; Xu Z; Jin H; Yang K ACS Nano; 2019 Nov; 13(11):12638-12652. PubMed ID: 31625721 [TBL] [Abstract][Full Text] [Related]
3. Turning Toxicants into Safe Therapeutic Drugs: Cytolytic Peptide-Photosensitizer Assemblies for Optimized In Vivo Delivery of Melittin. Jia HR; Zhu YX; Xu KF; Wu FG Adv Healthc Mater; 2018 Aug; 7(16):e1800380. PubMed ID: 29931753 [TBL] [Abstract][Full Text] [Related]
4. Combination Nano-Delivery Systems Remodel the Immunosuppressive Tumor Microenvironment for Metastatic Triple-Negative Breast Cancer Therapy. Bai L; Liu H; You R; Jiang X; Zhang T; Li Y; Shan T; Qian Z; Wang Y; Liu Y; Li C Mol Pharm; 2024 May; 21(5):2148-2162. PubMed ID: 38536949 [TBL] [Abstract][Full Text] [Related]
5. Light-activated hypoxia-sensitive biomimetic decoy efficiently cascading photodynamic-chemo therapy for breast cancer. Tang Z; Xu YC; Wang S; Huang J; Liu J; Ding M; Sun Y; Li N; Li H; Lin Y; Qin C Colloids Surf B Biointerfaces; 2024 Nov; 243():114145. PubMed ID: 39142000 [TBL] [Abstract][Full Text] [Related]
6. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy. Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794 [TBL] [Abstract][Full Text] [Related]
7. Peptide 18-4/chlorin e6-conjugated polyhedral oligomeric silsesquioxane nanoparticles for targeted photodynamic therapy of breast cancer. Kim YJ; Lee HI; Kim JK; Kim CH; Kim YJ Colloids Surf B Biointerfaces; 2020 May; 189():110829. PubMed ID: 32036332 [TBL] [Abstract][Full Text] [Related]
8. Dual-targeting of tumor cells and subcellular endoplasmic reticulum Ma K; Diao H; Xu X; Jin Y; Qiu M; Liu Z; Yang C; Zhao J; Chai S; Fang Q; Guo Z; Cui C; Xu J; Yin L; Ma HY Nanoscale; 2024 Jun; 16(25):12095-12106. PubMed ID: 38819371 [TBL] [Abstract][Full Text] [Related]
9. Bioinspired Hybrid Protein Oxygen Nanocarrier Amplified Photodynamic Therapy for Eliciting Anti-tumor Immunity and Abscopal Effect. Chen Z; Liu L; Liang R; Luo Z; He H; Wu Z; Tian H; Zheng M; Ma Y; Cai L ACS Nano; 2018 Aug; 12(8):8633-8645. PubMed ID: 30005164 [TBL] [Abstract][Full Text] [Related]
10. Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer. Fang H; Gai Y; Wang S; Liu Q; Zhang X; Ye M; Tan J; Long Y; Wang K; Zhang Y; Lan X J Nanobiotechnology; 2021 Mar; 19(1):81. PubMed ID: 33743740 [TBL] [Abstract][Full Text] [Related]
11. Tumor oxygenation nanoliposomes promote deep photodynamic therapy for triple-negative breast cancer. Han J; Xu X; Jin F; Xu X; Fang T; Du Y Biomater Sci; 2024 Sep; 12(19):4967-4979. PubMed ID: 39158634 [TBL] [Abstract][Full Text] [Related]
12. Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes. Yu X; Gao D; Gao L; Lai J; Zhang C; Zhao Y; Zhong L; Jia B; Wang F; Chen X; Liu Z ACS Nano; 2017 Oct; 11(10):10147-10158. PubMed ID: 28901740 [TBL] [Abstract][Full Text] [Related]
13. NIR-Triggered Sequentially Responsive Nanocarriers Amplified Cascade Synergistic Effect of Chemo-Photodynamic Therapy with Inspired Antitumor Immunity. Jin F; Qi J; Zhu M; Liu D; You Y; Shu G; Du Y; Wang J; Yu H; Sun M; Xu X; Shen Q; Ying X; Ji J; Du Y ACS Appl Mater Interfaces; 2020 Jul; 12(29):32372-32387. PubMed ID: 32597641 [TBL] [Abstract][Full Text] [Related]
14. Biomimetic "nano-spears" for CAFs-targeting: splintered three "shields" with enhanced cisplatin anti-TNBC efficiency. Wu Y; Chen R; Ni S; Hu K J Control Release; 2024 Jun; 370():556-569. PubMed ID: 38697316 [TBL] [Abstract][Full Text] [Related]
15. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles. Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252 [TBL] [Abstract][Full Text] [Related]
16. Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer. Scully MA; Wilkins DE; Dang MN; Hoover EC; Aboeleneen SB; Day ES Mol Pharm; 2023 Aug; 20(8):3895-3913. PubMed ID: 37459272 [TBL] [Abstract][Full Text] [Related]
17. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity. Ye R; Zheng Y; Chen Y; Wei X; Shi S; Chen Y; Zhu W; Wang A; Yang L; Xu Y; Peng J ACS Appl Mater Interfaces; 2021 Dec; 13(47):55902-55912. PubMed ID: 34793125 [TBL] [Abstract][Full Text] [Related]
18. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223 [TBL] [Abstract][Full Text] [Related]
19. Light-inducible nanodrug-mediated photodynamic and anti-apoptotic synergy for enhanced immunotherapy in triple-negative breast cancer. Huang J; Liu X; Lin M; Xiao Z; Shuai X Biomater Sci; 2024 May; 12(10):2639-2647. PubMed ID: 38563394 [TBL] [Abstract][Full Text] [Related]
20. Platelet Membrane-Camouflaged Silver Metal-Organic Framework Biomimetic Nanoparticles for the Treatment of Triple-Negative Breast Cancer. Liu H; Cai G; Yuan S; Zhou X; Gui R; Huang R Mol Pharm; 2024 Jul; 21(7):3577-3590. PubMed ID: 38857525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]